Back

Treg cell epitopes from α-tubulin: discovery and immunomodulatory features

Fiyouzi, T.; Subiza, J. L.; Lafuente, E. M.; Reche, P. A.

2025-01-13 immunology
10.1101/2025.01.08.631899 bioRxiv
Show abstract

Regulatory T (Treg) cells are pivotal in maintaining self-tolerance and controlling immune responses. In this study, we investigated potential Treg cell epitopes in human -tubulin that were selected in silico for their promiscuous binding to class II human leukocyte antigens and full identity with antigens from enteric nematodes present in excretory-secretory products. We identified five Treg cell epitopes in -tubulin that were capable of stimulating and expanding IL-10 and TGF-{beta}-producing Foxp3+ Treg cells in peripheral blood mononuclear cells. We also proved that a peptide pool containing the identified Treg cell epitopes (TBL pool) suppressed the T cell responses elicited by different stimuli, including LPS, and class I and class II restricted T cell epitopes, as determined by intracellular cytokine staining assays. Similarly, this same peptide pool was able to suppress T cell responses in mixed lymphocyte reactions. Finally, we found that stimulation of naive CD4+ T cells with autologous monocyte-derived dendritic cells in the presence of the TBL pool promoted the differentiation of functional CD4+CD25highFoxP3+ T cells capable of suppressing the proliferation of CD3/CD28-activated T cells. -tubulin Treg cell epitopes could be useful for treating autoimmune and chronic inflammatory diseases by inducing Treg cells and, given the ubiquitous and copious expression of -tubulin, enable a general mechanism of immune homeostasis.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cellular & Molecular Immunology
14 papers in training set
Top 0.1%
22.8%
2
Frontiers in Immunology
586 papers in training set
Top 0.4%
12.6%
3
Cell Discovery
54 papers in training set
Top 0.6%
6.9%
4
eLife
5422 papers in training set
Top 11%
6.9%
5
iScience
1063 papers in training set
Top 3%
4.0%
50% of probability mass above
6
Allergy
23 papers in training set
Top 0.2%
2.6%
7
Cell Reports
1338 papers in training set
Top 19%
2.5%
8
Scientific Reports
3102 papers in training set
Top 47%
2.4%
9
Advanced Science
249 papers in training set
Top 8%
2.1%
10
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.8%
11
PLOS Pathogens
721 papers in training set
Top 6%
1.7%
12
PLOS ONE
4510 papers in training set
Top 58%
1.3%
13
Molecular Immunology
14 papers in training set
Top 0.3%
1.2%
14
The Journal of Immunology
146 papers in training set
Top 1%
1.1%
15
Cell Reports Medicine
140 papers in training set
Top 6%
1.0%
16
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 5%
1.0%
17
Computational and Structural Biotechnology Journal
216 papers in training set
Top 7%
0.9%
18
Vaccines
196 papers in training set
Top 2%
0.9%
19
eBioMedicine
130 papers in training set
Top 4%
0.8%
20
PLOS Biology
408 papers in training set
Top 19%
0.8%
21
BMC Biology
248 papers in training set
Top 4%
0.8%
22
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 9%
0.8%
23
International Journal of Biological Macromolecules
65 papers in training set
Top 4%
0.7%
24
Immunology
29 papers in training set
Top 1%
0.7%
25
Cancer Immunology Research
34 papers in training set
Top 0.6%
0.7%
26
International Journal of Molecular Sciences
453 papers in training set
Top 19%
0.5%
27
Horticulture Research
43 papers in training set
Top 2%
0.5%
28
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 7%
0.5%
29
Nature Communications
4913 papers in training set
Top 67%
0.5%
30
Structure
175 papers in training set
Top 4%
0.5%